Commentary

Experts share key takeaways on data presented at the 2019 Crohn’s & Colitis Congress.

Research Advances and Clinical Impact of New Data From Crohn’s & Colitis Congress® 2019

​Disease and Drug Monitoring in IBD: My Take on Data From Crohn’s & Colitis Congress 2019

By D. Brent Polk, MD, AGAF

ClinicalThought Commentary activity link: https://www.clinicaloptions.com/immunology/conference-coverage/lasvegas2019/clinicalthought/ct1/page-1

New and Emerging IBD Treatments: Our Take on Data From Crohn’s & Colitis Congress 2019

By Baldeep S. Pabla, MD, MSCI and Davida A. Schwartz, MD, FACG, AGAF

ClinicalThought Commentary activity link: https://www.clinicaloptions.com/immunology/conference-coverage/lasvegas2019/clinicalthought/ct2/page-1